Biontech Se Sponsored Adr Stock News

Decreasing concerns about the omicron variant are leading to declining prices for these vaccine stocks.

Pfizer and BioNTech are to test a third dose of their Covid vaccine on infants and children aged 6 months to 5 years old after the big pharma giant claimed that two doses failed to [] The post Pfizer To Test 3rd Covid Jab In Children Under 5 appeared first on News Punch .

BioNTech SE (NASDAQ:BNTX) traded at $275.23 at close of the session on Monday, 12/20/21, made a downward move of -4.19% on its previous day’s price. Looking at the stock we see that its previous close was $287.28 with the day’s price range being $275.00 – $302.34. The company has a trailing 12-month PE ratio of … Before You Invest, Make Sure You Check This BioNTech SE (NASDAQ: BNTX) Analysis Read More »

It had much to do with a certain Greek letter.

Pfizer Inc. PFE, -2.89% and German partner BioNTEch SE BNTX, +1.27% said Monday they have reached an agreement to provide an additional 200 million doses of their COVID-19 vaccine to the European Comm

The European Commission said on Sunday it had reached an agreement with BioNTech and Pfizer for an extra 20 million doses of their COVID-19 vaccine to be delivered to EU member states in the first quarter of 2022. These doses come on top of an already scheduled 195 million doses from BioNTech-Pfizer, bringing the total number of deliveries []

Brussels, Dec 20 (IANS) The member states of the European Union (EU) will receive an additional 20 million doses of the Pfizer-BioNTech vaccine in the first three months of next year to hasten the pace against the fast-spreading Omicron variant, the European Commission has said. The Commission has today agreed with BioNTech-Pfizer to accelerate the [] The post EU to supply 20mn additional vaccine doses to fight Omicron variant appeared first on Buziness Bytes .

The European Commission has agreed with BioNtech-Pfizer to accelerate the delivery of an additional 20 million vaccine doses as the content struggles to contain the Omicron coronavirus variant. The post EU orders additional 20 million vaccines as Omicron variant spreads appeared first on Newsbook .

The European Commission agreed on December 19 with BioNtech-Pfizer to accelerate the delivery of its mRNA vaccine against Covid-19 to EU member states, starting in a few weeks, the Commission said.

Don't expect the momentum to dwindle for these stocks.

Banque Cantonale Vaudoise cut its stake in BioNTech SE (NASDAQ:BNTX) by 3.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,685 shares of the companys stock after selling 365 shares during the period. Banque Cantonale Vaudoises holdings in BioNTech were []

The US Centers for Disease Control and Prevention (CDC) changed its recommendations for Covid-19 vaccines Thursday to make clear that shots made by Moderna and Pfizer/BioNTech are preferred over Johnson & Johnsons vaccine. The new recommendation now reads, mRNA vaccines are preferred over the Janssen Covid-19 vaccine for the prevention of Covid-19 for those 18 The post CDC Recommends Pfizer and Moderna Vaccines Over J&J Due to Rare Side Effects appeared first on HillReporter.com .

Pfizer and BioNtech announced Friday they will test a third dose of their COVID-19 vaccine in children 5 and younger.

BioNTech SE (NASDAQ:BNTX) shares, rose in value on Thursday, 12/16/21, with the stock price down by -1.17% to the previous day’s close as strong demand from buyers drove the stock to $283.68. Actively observing the price movement in the last trading, the stock closed the session at $287.05, falling within a range of $277.00 and … BioNTech SE (NASDAQ: BNTX): Moving Toward A Higher Share Price Read More »